Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).
Boucau J, Uddin R, Marino C, Regan J, Flynn JP, Choudhary MC, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Turbett SE, Li JZ, Lemieux JE, Barczak AK, Siedner MJ.
Boucau J, et al. Among authors: vyas jm, vyas td.
Clin Infect Dis. 2023 Feb 8;76(3):e526-e529. doi: 10.1093/cid/ciac512.
Clin Infect Dis. 2023.
PMID: 35737946
Free PMC article.